Talia Faison

Center for Drug Evaluation and Research,

Office of Product Quality,

Office of Biotechnology Products,

Division of Biotechnology Review and Research II,

Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II

U.S. Food and Drug Administration

我们使用 cookie 来增强您在我们网站上的体验。

继续使用我们的网站或单击“继续”,即表示您同意接受我们的 cookie。